Search
for
Sort by
Research 151–180 of 1000+
- Efficacy and Safety of Tofacitinib in Paediatric Alopecia Aerata - A Prospective Observational Study
- Rapidly Progressive Alopecia Universalis after Varicella-Zoster Virus Infection: The role of Immune Dysregulation and Tofacitinib treatment
- Dissecting Cellulitis of the Scalp Successfully Treated with a Combination of Ixekizumab and Tofacitinib
- Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients
- A Novel Topical Compound Gel Loading Minoxidil and Tofacitinib for Treatment of Alopecia Areata: Formulation, Characterization, and In Vitro/In Vivo Evaluation
- Characteristics and predictive values of super-responders in alopecia areata under tofacitinib treatment: A single-center retrospective study
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Tofacitinib in alopecia areata and HIV: A curious intersection of immunomodulation, hair regrowth, and hypertrichosis
- Trachyonychia secondary to pediatric alopecia areata responding to oral tofacitinib therapy: a case report and review of literature
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- P0881 Effectiveness and Safety of Tofacitinib in Biologic-Naïve Elderly Patients with Ulcerative Colitis
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- S116 Treatment of Concomitant Alopecia Areata and Crohn’s Disease in a Young Child With Tofacitinib: Case Report
- Therapeutic potential of oral tofacitinib in alopecia areata: a retrospective study
- Successful treatment of resistant alopecia totalis with tofacitinib
- Circumscribed Alopecia Areata Incognita and Response to Tofacitinib
- Nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of tofacitinib for treating alopecia areata
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Efficacy of tofacitinib as an induction agent in severe alopecia areata compared to oral betamethasone weekly pulse
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
- Tofacitinib treatment in a severe pediatric alopecia areata: A case report and a literature review
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Effectiveness and Predictive Factors of Response to Tofacitinib Therapy in 125 Patients with Alopecia Areata: A Single-centre Real-world Retrospective Study